Harris Sliwoski LLP Partner Jason Adelstone was joined by Matthew John Strait, former Deputy Assistant Administrator in the DEA’s Diversion Control Division; Mark Caplin, Founder and CEO of CannaGen; and Dr. Gillian Schauer, Executive Director of the Cannabis Regulators Association (CANNRA).
The discussion brought together legal, federal enforcement, state regulatory, and industry perspectives to examine the practical implications of marijuana rescheduling and the evolving federal cannabis regulatory landscape.
What the Webinar Covers
The panel explored several issues facing cannabis and hemp businesses, including:
- How moving marijuana to Schedule III could affect federal regulation and DEA enforcement.
- What businesses should understand about DEA inspections, registration, recordkeeping, and compliance.
- The relationship between federal enforcement priorities and existing state cannabis regulatory programs.
- Challenges surrounding hemp and marijuana classification, testing, and supply-chain tracing.
- Potential areas of increased federal scrutiny and practical considerations for assessing enforcement risk.
With continued uncertainty surrounding federal cannabis policy and its implementation, this conversation offers perspectives on the regulatory and enforcement challenges businesses may face as the landscape evolves.